956499-75-5

Basic information

• Product Name: 6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine
• Synonyms: 6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine
• CAS NO: 956499-75-5
• Molecular Weight: 289.131
• Mol File: 956499-75-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine(956499-75-5)
• EPA Substance Registry System: 6-bromo-2-(4 - hydroxyphenyl)imidazo[1,2-a]pyridine(956499-75-5)

Safety Data

• Hazardous Substances Data: 956499-75-5(Hazardous Substances Data)

Upstream product

• 7789-45-9 copper(II)bromide 
• 99-93-4 4-Hydroxyacetophenone 
• 1072-97-5 5-bromo-2-pyridylamine 
• 2491-38-5 2-bromo-1-(4'-hydroxyphenyl)-1-ethanone 

Downstream Products

• 958641-69-5 6-bromo-2-[4'-(2''-fluoroethoxy)phenyl]imidazo[1,2-a]pyridine 
• 958641-66-2 6-bromo-2-[4'-(2''-p-toluenesulfonyloxyethoxy)phenyl]imidazo[1,2-a]pyridine 
• 956499-72-2 6-tributylstannyl-2-(4'-hydroxyphenyl)imidazo[1,2-a]pyridine 
• 958641-86-6 6-bromo-2-[4'-(3-hydroxypropoxy)phenyl]imidazo[1,2-a]pyridine 
• 958641-67-3 6-bromo-2-[4'-(3''-fluoropropoxy)phenyl]imidazo[1,2-a]pyridine 

Relevant articles and documents

USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME

The invention provides a reagent for detecting amyloid in a biological tissue which can detect amyloid in vitro and in vivo with high sensitivity using a compound which has affinity with amyloid and is suppressed in toxicity such as mutagenicity. The reagent for detecting amyloid deposited in a biological tissue comprises the compound represented by the following formula (1) or a salt thereof: wherein A1, A2, A3 and A4 independently represent a carbon or a nitrogen, and R3 is a group represented by the following formula: wherein R1 is a radioactive halogen substituent; m is an integer of 0 to 4; and n is an integer of 0 or 1, provided that at least one of A1, A3, A3 and A4 represents a carbon, and R5 binds to a carbon represented by A1, A2, A3 or A4.

NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID

The present invention provides a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagencity. Provided is a compound represented by the following formula (1) or a salt thereof: wherein A1, A2, A3 and A4 independently represents a carbon or nitrogen; R1 is a halogen substituent; R2 is a halogen substituent; and m is an integer of 0 to 2, provided that at least one of R1 and R2 is a radioactive halogen substituent, at least one of A1, A2, A3 and A4 represents a carbon, and R1 binds to a carbon represented by A1, A2, A3 or A4 as well as a low-toxic diagnostic agent comprising a compound represented by the preceding formula or a salt thereof.

NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID

A compound that has affinity with amyloid, exhibits sufficiently rapid clearance from normal tissues, and is suppressed in toxicity such as mutagenicity is provided, which is represented by the following formula (1): or a salt thereof, wherein R1 is a group selected from hydrogen, hydroxyl group, carboxyl group, sulfate group, amino group, nitro group, cyano group, an alkyl substituent with one to 4 carbon atoms or an alkoxy substituent with one to 4 carbon atoms; R2 is a radioactive halogen substituent; and m is an integer of 0 to 2, and a low-toxic diagnostic agent for Alzheimer's disease comprising a compound represented by the above formula or a salt thereof is also provided.